✦ LIBER ✦

P.4.020 Efficacy and tolerability of memantine in nursing home patients with moderate to severe dementia of the Alzheimer's type

✍ Scribed by B. Winblad; G. Lee; H.-J. Möbius; S. McDonald; S. Graham

Book ID: 119577249
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 137 KB
Volume: 13
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(03)92215-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

P4-329: Post HOC responder analyses of M

P4-329: Post HOC responder analyses of Memantine treatment on behavioral disturbances in patients with moderate to severe Alzheimer's disease

✍ Stender, Karina; Cummings, Jeffrey 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A Systematic Review of the Clinical and

A Systematic Review of the Clinical and Cost-Effectiveness of Memantine in Patients with Moderately Severe to Severe Alzheimer’s Disease

✍ Joanna Kirby, Mr Colin Green, Emma Loveman, Andrew Clegg, Joanna Picot… 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 155 KB

P.5.a.017 Effects of memantine on langua

P.5.a.017 Effects of memantine on language and functional communication in patients with moderate to severe Alzheimer's disease

✍ M. Tocco; S.M. Graham 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Long-term efficacy of olanzapine in the

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia

✍ Jamie S. Street; W. Scott Clark; Deborah L. Kadam; Steven J. Mitan; Beth E. Juli 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Open label, multicenter, 28-week extensi

Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB